LINACLOTIDSYNTHESEVERFAHREN

European patent · EP3392266 · In force

Register entry

Publication number
EP3392266
Application number
EP16874867
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 15, 2016
Published
Oct 24, 2018
Granted
May 27, 2020
Protection ends at the latest
Dec 14, 2036
Next annual fee due
Dec 31, 2026
IPC classes
C07K 7/08 (2006.01)
C07K 1/06 (2006.01)
Priority
CN 201510964573 18.12.2015
PCT application
PCT/CN2016/110106 15.12.2016
PCT publication
WO2017/101810 22.06.2017
Filing language
Chinese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 22, 2026

    Change

    Published in Swissreg on 22.01.2026

  2. Jan 30, 2025

    Change

    Published in Swissreg on 30.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 31, 2023

    Change

    Published in Swissreg on 31.01.2023

  5. Jul 17, 2020

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 17.07.2020

  6. May 27, 2020

    Granted

    Published in Swissreg on 27.05.2020

Parties

Holder

Hybio Pharmaceutical Co., Ltd.

4th Floor Office Building, Hybio Medicine Park, Hi-Tech Industrial Park Central, Nanshan District, Shenzhen, Guangdong 518057, CN

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

YUAN, Jiancheng

Shenzhen Guangdong 518057, CN

TAO, Anjin

Shenzhen Guangdong 518057, CN

CHEN, Xueming

Shenzhen Guangdong 518057, CN

WU, Jingkang

Shenzhen Guangdong 518057, CN

MI, Pengcheng

Shenzhen Guangdong 518057, CN

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.